Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Merck & Co Inc has a consensus price target of $127.68 based on the ratings of 26 analysts. The high is $155 issued by Cantor Fitzgerald on September 16, 2024. The low is $102 issued by Daiwa Capital on July 7, 2022. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Cantor Fitzgerald, and Barclays on September 16, 2024, August 29, 2024, and July 31, 2024, respectively. With an average price target of $150.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Barclays, there's an implied 31.36% upside for Merck & Co Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Merck & Co (NYSE:MRK) was reported by Cantor Fitzgerald on September 16, 2024. The analyst firm set a price target for $155.00 expecting MRK to rise to within 12 months (a possible 35.14% upside). 41 analyst firms have reported ratings in the last year.
The latest analyst rating for Merck & Co (NYSE:MRK) was provided by Cantor Fitzgerald, and Merck & Co reiterated their overweight rating.
The last upgrade for Merck & Co Inc happened on January 4, 2024 when TD Cowen raised their price target to $135. TD Cowen previously had a market perform for Merck & Co Inc.
The last downgrade for Merck & Co Inc happened on March 11, 2024 when Societe Generale changed their price target from N/A to $104 for Merck & Co Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Merck & Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Merck & Co was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.
While ratings are subjective and will change, the latest Merck & Co (MRK) rating was a reiterated with a price target of $155.00 to $155.00. The current price Merck & Co (MRK) is trading at is $114.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.